RxDoctor Payments Data

Heather Shoup

Gerontology · Dayton, OHNPI 1407251523

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,214 of the $5,074 with a category attached, or 83.1%. It is spread thinly across 45 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations. Among gerontology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,074in general payments, 2019–2025

Across 172 payments — averaging $29.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$710
  • Ferring Pharmaceuticals Inc.$471
  • Bayer$413
  • Astellas Pharma US Inc$387
  • Teleflex LLC$298
  • Medtronic$218
  • plus $3K from 39 others

What the payments were for

  • Consulting fees$4509%
  • Food & beverage$4,21483%
  • Education$4108%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,074 in reported general payments places this provider in the 90th percentile of 361 gerontology providers in Ohio.

See all gerontology providers in Ohio

Medicare billing

Part B allowed, 2024
$97,026
Medicare patients
544
Services billed
2,202

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron55$56,614
GemtesaVibegron14$15,881
Tamsulosin Hcl816$12,112
Silodosin92$9,503
Solifenacin Succinate25$3,238
Potassium Citrate ErPotassium Citrate45$2,950
Finasteride241$2,449
NitrofurantoinNitrofurantoin Macrocrystal27$1,354
Oxybutynin Chloride ErOxybutynin Chloride38$1,316
Dutasteride47$923
Estradiol21$885
Alfuzosin Hcl ErAlfuzosin Hcl40$600
Testosterone Cypionate12$593
Oxybutynin Chloride24$544
CefuroximeCefuroxime Axetil25$504

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$387$56,61455 claims
Sumitomo Pharma America, Inc.Gemtesa$202$15,88114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 361 gerontology providers in Ohio.

Other gerontology in Dayton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →